Add BrightSurf on Google Email

Science News for November 20, 2002


Genetic clash doubles schizophrenia risk

A new study by UCLA researchers found that Rh-incompatible mothers are more than twice as likely to have children with schizophrenia. The study mapped genetic data from 181 Finnish families and discovered a significant link between the RHD gene and schizophrenia risk.

SourceUniversity of California - Los Angeles·JournalAmerican Journal of Human Genetics·DateNov 20, 2002
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

Rice Connexions program receives funding from Hewlett Foundation

The Rice Connexions program is expanding its offerings with new software tools and partnerships, making high-quality educational content freely available worldwide. The project aims to empower diverse cultural communities and break down barriers between academic disciplines through a collaborative approach to teaching materials.

SourceRice University·DateNov 20, 2002

Young mothers' marital status not age, linked to later depression

Researchers found that living in a female-headed family at age 14, having low self-esteem, and poor verbal/math skills predicted depressive symptoms in young adulthood. The study also highlighted the need to disentangle women's marital status from their age at first birth.

SourceCenter for Advancing Health·JournalChild Development·DateNov 20, 2002
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Getting the jump on hackers

Virginia Tech researchers are working on ways to protect battery-operated computers and wireless devices from hacking attempts that can drain their batteries. The project aims to develop built-in measures to prevent such attacks, which could become a major concern for the wireless industry.

SourceVirginia Tech·DateNov 20, 2002

Major herpes vaccine trial launched in women

A major herpes vaccine trial is underway for women to prevent genital herpes, with over 70% of HSV-1 and HSV-2 negative women showing protection against the disease. The trial aims to recruit thousands of HSV-negative women to test the efficacy of a subunit vaccine containing a piece of the virus outer coat.

SourceNIH/National Institute of Allergy and Infectious Diseases·DateNov 20, 2002
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Lack of harmony in European clinical trial regulations is hurting patients

The lack of harmonization in European clinical trial regulations is jeopardizing progress in state-of-the-art treatment strategies, denying patients the benefits of advances. This is particularly concerning in complex fields like cancer research, where multi-disciplinary and multi-modality treatment is required.

SourceEuropean Organisation for Research and Treatment of Cancer·DateNov 20, 2002
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

Sleep apnea linked to early brain damage

Researchers found dramatic gray matter loss in the brains of men with sleep apnea, primarily in regions controlling speech production, movement, and emotion. The severity of brain damage correlated directly with disorder severity, suggesting that early brain wiring abnormalities may contribute to sleep apnea onset.

SourceUniversity of California - Los Angeles·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateNov 20, 2002

Want hypertension? Hurry up!

A pioneering study found that time urgency and impatience during young adulthood are associated with increased risk of developing hypertension years later. The strongest link was seen among white men, who were more than three times as likely to develop high blood pressure as those in lower TUI groups.

SourceAmerican Heart Association·DateNov 20, 2002

Ag economist calculates value of knowing that food's safe

A study by Purdue economist William Masters found that African mothers are willing to pay a premium of 30% for infant food with guaranteed quality and safety information. This could lead to reduced child malnutrition rates if generic options were made available, saving up to 6 million lives annually.

SourcePurdue University·JournalAmerican Journal of Agricultural Economics·DateNov 20, 2002
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

First potentially clinically useful independent marker for lung cancer identified

A study by researchers at the H.Lee Moffitt Cancer Center has identified the ERCC1 gene as a potentially clinically useful independent marker for lung cancer. Patients with high levels of ERCC1 are more likely to survive after surgery and may benefit from platinum-based chemotherapy, while those with low levels have a poorer prognosis.

SourceEuropean Organisation for Research and Treatment of Cancer·DateNov 20, 2002

Drug combination opens clogged arteries faster, keeps them open longer

Duke University Medical Center researchers found that a new drug combination, combining eptifibatide and tenecteplase, speeds up and sustains restored blood flow to the heart. The study showed significant improvements in ECG readings, with patients receiving the combination therapy returning to stable levels within 55 minutes.

SourceDuke University Medical Center·DateNov 20, 2002

Pre-clinical studies identify novel ways to enhance effect of chemotherapy

Researchers found that inhibiting PDGF signalling increases tumour uptake of cytotoxic drugs without increasing toxicity. Combination therapies with Glivec and other drugs induced better anti-tumour effects in animal models, suggesting a new strategy for improving drug treatment for cancer patients.

SourceEuropean Organisation for Research and Treatment of Cancer·DateNov 20, 2002
GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

$750,000 NYSTAR grant for biosensor development

Craighead's research focuses on developing chip-based chemical and biochemical analysis systems with high-speed capabilities. He aims to create rapid medical diagnosis or environmental monitoring tools using microfluidic systems and engineered nanostructures.

SourceCornell University·DateNov 20, 2002

First results from novel anti-angiogenic drug trial in patients

A Phase I study of the novel anti-angiogenic drug SU011248 showed promising results in patients with advanced cancers that had failed to respond to other therapies. The drug demonstrated activity in a range of tumour types, including renal and gastrointestinal cancers, but did not show efficacy against brain metastases.

SourceEuropean Organisation for Research and Treatment of Cancer·DateNov 20, 2002
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.